stockrow
Friday 6 November 2026
Export HLN’s income statement to Excel — free account
Haleon PLC Sponsored ADR
HLN Healthcare Drug Manufacturers Specialty & Generic
Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.
8.97
0.18
−1.97%
Follow HLN
Alert me
Haleon PLC Sponsored ADR (HLN) Gross margin
Haleon PLC Sponsored ADR's gross margin over the twelve months to 30 September 2024 was 62.2%. Over the past ten years it has ranged from 56.6% (fiscal 2019) to 64.2% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 64.2% | 3.44 |
| FY2024 | 60.8% | 1.05 |
| FY2023 | 59.7% | (0.87) |
| FY2022 | 60.6% | (1.77) |
| FY2021 | 62.3% | 2.59 |
| FY2020 | 59.8% | 3.12 |
| FY2019 | 56.6% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2024 | 62.9% | (0.09) |
| Mar 2024 | 63.0% | 1.64 |
| Sep 2023 | 61.3% | (0.61) |
| Jun 2023 | 61.9% | 0.32 |
| 1 more quarters | Free account |
Against its own ten years
Low 56.6%
High 64.2%
Ten-year median
60.6%
Current reading's percentile
100
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| UTHR United Therapeutics Corporation compare | 86.3% |
| ZTS Zoetis Inc. compare | 71.7% |
| TAK Takeda Pharmaceutical Co. compare | 65.9% |
| HLN Haleon PLC Sponsored ADR | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 53.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on HLN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- Beneish M-score
- The full statement